Yissum - Research Development Company of the Hebrew University

Research & Services | Modern cell and molecular biology research of diabetes

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Research Services and Capabilities · Israel

Summary of the technology

Research & Services | Modern cell and molecular biology research of diabetes
Project ID : 34-2010-2440

Description of the technology

New targets and novel classes of compounds for Type 2 Diabetes

Categories

Life Sciences; Diabetes

Laboratory for Pharmacological Diabetes Research. Institute for Drug Research, Dept. of Pharmacology School of Pharmacy, Faculty of Medicine, the Hebrew University

Research Topics:

  • Development of antidiabetic drugs

  • Molecular mechanism of macro-vascular complication in diabetes

  • Role of lipid peroxidation in the development of diabetes-related complications

  • Molecular factors that determine normal and aberrant interactions between insulin producing beta-cells and microcapillary endothelial cell in Islets of Langerhans

Research Capabilities:

  • We designed synthesized and patented novel drugs that increase the rate of glucose transport in skeletal muscles by activating AMPK and recruiting the glucose transport-4 (GLUT-4). These compounds reduced blood glucose levels in animal models of diabetes. In parallel, we have developed a new class of unrelated compounds that increase the rate of glucose transport in skeletal muscles and diabetic animals. Another family of compounds under development are activators of the intrinsic activity of GLUT-4 in the plasma membrane of skeletal muscles.

  • We have perfected extraction methods and HPLC protocols for the analysis and quantification of 4-hydroxyalkenals in plasma, tissue culture media and cell homogenates.

Advantages

Novel drugs for the treatment of Type-2 diabetes are sought. Therefore, research effort to discover new targets for such drugs and the development of active, safe and orally deliverable such compounds are intensive. We offer such new targets and novel classes of compounds that may meet these criteria.

Research Background

The laboratory is engaged in various aspects of diabetes research and combines modern cell and molecular biology research, the use of animal models of diabetes and design and synthesis of novel molecules with antihyperglycemic potential.

Available Resources

  • We have developed a cell-fluorescent-based system to follow and study beta-cell and endothelial cell interactions. This assay is sensitive and can be used for screening of new compounds and drugs and their effects on this complex heterologous cell:cell interactions.

  • Resources for pharmaceutical chemistry, cell biology and molecular biology research. Use of animal models of diabetes. Advanced lipid peroxidation research.

  • We use various methods to measure glucose transport in cultures skeletal muscle cells, in mouse and rat isolated skeletal muscles.

  • We routinely perform kinetic analysis of the glucose transport rate in cultures cells.

  • We also employ routine methods to measure the abundance of glucose transporters (GLUTs) in the plasma membrane of skeletal muscle fibbers and other cells.

Project manager

Itzik Goldwaser
VP, Head of Research Collaborations

Project researchers

Shlomo Sasson
HUJI, School of Pharmacy
Pharmacology

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Clean Industrial Technologies
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Clinical Medicine
  • Anatomy, Pathology, Immunology, Physiology
  • Agro and Marine biotech
  • Other Medical/Health Related
  • Therapeutic
  • Diagnostic
  • Other (uncategorised)
  • Life Science & Biotechnology
  • metabolic

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.